Cerus (CERS) Inventory Turnover Ratio, from third quarter 2026 to third quarter 2025, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket
 
Cerus Corporation  (NASDAQ: CERS)
 

Cerus Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

According to the latest Balance sheet Sep 30 2026, Cerus Corporation has not recorded any inventories.
Visit Cerus Corporation Balance sheet

Within Healthcare sector 330 other companies have achieved higher inventory turnover ratio. While Inventory turnover ratio total ranking has improved so far during the III Quarter 2026, to 1645, from total ranking in the second quarter 2026 at 1869.

CERS Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Cerus Corporation Market Share?

What is Inventory Turnover Ratio?




CERS Inventory Turnover Ratio (Sep 30 2026)
III. Quarter
(Jun 30 2026)
II. Quarter
(Mar 31 2026)
I. Quarter
(Dec 31 2025)
IV. Quarter
(Sep 30 2025)
III. Quarter
Y / Y Inventory Growth 21.74 % 20.69 % 26.91 % 47.05 % 45.43 %
Y / Y Cost of Sales Growth - - 47.06 % 20.83 % 26.32 %
Inventory Turnover Ratio (TTM) - - 1.8 1.76 1.81
CERS's Total Ranking # 1645 # 1869 # 1669 # 1658 # 1608
Average inventory processing period - - 203 208 201
Seq. Inventory Growth -1.71 % 7.67 % 8.95 % 5.57 % -2.55 %
Seq. Cost of Sales Growth - - -13.79 % 20.83 % 4.35 %




Inventory Turnover Ratio Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 148
Healthcare Sector # 331
Overall Market # 1645

Inventory Turnover Ratio Statistics
High Average Low
2.69 1.93 0.87
(Sep 30 2022)   (Sep 30 2026)




Financial Statements
Cerus's Inventories $ 65 Millions Visit CERS's Balance sheet
Cerus's Cost of Revenues TTM $ 54 Millions Visit CERS's Income Statement
What are CERS's Sales? Visit CERS's Sales by Segment

Other Inventory Turnover Ratios
Cerus's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Medical Equipment & Supplies Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
CERS's Inventory Turnover Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for CERS's Competitors
Inventory Turnover Ratio for CERS's Suppliers
Inventory Turnover Ratio for CERS's Customers

You may also want to know
CERS's Sales Growth Rates CERS's Pe Price to earnings ratio CERS's Receivables Turnover Ratio CERS's Stock Quote
CERS's Net Income Growth Rates CERS's Ps Price to Sales ratio CERS's Sales per Employee CERS's Asset Turnover Ratio
CERS's Net Margin CERS's Pb Price to Book ratio CERS's Financial Strength Ratios CERS's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Sep 30 2026, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Sep 30 2026 Inventories at quarter ending Sep 30 2026
Merit Medical Systems Inc  2.25 $ 817.001  Millions$ 363  Millions
Bioventus Inc   2.24 $ 183.856  Millions$ 82  Millions
Johnson and Johnson  2.17 $ 32,222.000  Millions$ 14,824  Millions
Glaukos Corp  2.13 $ 131.180  Millions$ 62  Millions
Organon and Co   2.08 $ 2,859.000  Millions$ 1,371  Millions
Repligen Corp  2.07 $ 372.472  Millions$ 180  Millions
Boston Scientific Corporation  2.06 $ 6,502.000  Millions$ 3,153  Millions
Bausch and Lomb Corp  2.01 $ 1,986.000  Millions$ 990  Millions
Clearpoint Neuro Inc   1.98 $ 17.564  Millions$ 9  Millions
Intuitive Surgical Inc   1.91 $ 3,799.300  Millions$ 1,986  Millions
Indivior Pharmaceuticals Inc   1.88 $ 208.000  Millions$ 111  Millions
Tenet Healthcare Corp  1.88 $ 642.000  Millions$ 342  Millions
Iradimed Corporation  1.78 $ 21.878  Millions$ 12  Millions
Axsome Therapeutics Inc   1.67 $ 58.422  Millions$ 35  Millions
Insmed Inc  1.66 $ 237.067  Millions$ 143  Millions
Stryker Corp  1.66 $ 9,116.000  Millions$ 5,499  Millions
Integra Lifesciences Holdings Corp  1.62 $ 789.329  Millions$ 486  Millions
Conmed Corporation  1.61 $ 580.951  Millions$ 361  Millions
Axogen inc   1.49 $ 68.923  Millions$ 46  Millions
Aurinia Pharmaceuticals Inc   1.29 $ 30.165  Millions$ 23  Millions
Alphatec Holdings Inc   1.27 $ 241.341  Millions$ 189  Millions
Bridgebio Pharma Inc   1.24 $ 53.542  Millions$ 43  Millions
Biogen Inc   1.23 $ 2,681.800  Millions$ 2,181  Millions
Kiniksa Pharmaceuticals International Plc  1.21 $ 93.072  Millions$ 77  Millions
Penumbra Inc  1.13 $ 499.548  Millions$ 443  Millions
Neurocrine Biosciences Inc   1.07 $ 81.200  Millions$ 76  Millions
Amarin Corp Plcuk  0.92 $ 104.502  Millions$ 113  Millions
Eli Lilly And Company  0.89 $ 14,149.700  Millions$ 15,815  Millions
Cerus Corporation  0.87 $ 54.000  Millions$ 62  Millions
Inspire Medical Systems inc   0.74 $ 122.959  Millions$ 165  Millions

Date modified: 2026-11-03T09:56:51+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.